Moody National Bank Trust Division Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Moody National Bank Trust Division lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,099 shares of the healthcare conglomerate’s stock after buying an additional 24 shares during the quarter. UnitedHealth Group makes up about 0.4% of Moody National Bank Trust Division’s investment portfolio, making the stock its 23rd largest holding. Moody National Bank Trust Division’s holdings in UnitedHealth Group were worth $4,501,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC boosted its holdings in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC acquired a new position in UnitedHealth Group in the fourth quarter worth $31,000. LFA Lugano Financial Advisors SA boosted its holdings in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the period. Finally, Transcendent Capital Group LLC acquired a new position in UnitedHealth Group in the fourth quarter worth $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on UNH shares. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. JPMorgan Chase & Co. raised their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Wells Fargo & Company cut their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Morgan Stanley cut their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

View Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $481.05 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The company’s 50-day moving average price is $495.26 and its two-hundred day moving average price is $504.85. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The stock has a market cap of $442.75 billion, a PE ratio of 29.40, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the business posted $6.26 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be paid a $2.10 dividend. The ex-dividend date is Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.75%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.